Kotha J Subbaramaiah

Title: Kotha J Subbaramaiah: Innovator in Medical Treatments

Introduction

Kotha J Subbaramaiah is a notable inventor based in Flushing, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing diseases caused by human papillomavirus (HPV) and cancers associated with HER-2/neu overexpression. With a total of 4 patents to his name, his work has the potential to impact many lives.

Latest Patents

Subbaramaiah's latest patents focus on innovative treatments. One patent addresses the treatment of HPV-caused diseases by downregulating HPV protein expression through the administration of PPARγ ligands, selective inhibitors of cyclooxygenase-2 (COX-2), and certain non-steroidal anti-inflammatory drugs. Another patent targets cancers associated with HER-2/neu overexpression, utilizing a selective COX-2 inhibitor either as a standalone treatment or in combination with HERCEPTIN® and standard therapies. These treatments are particularly relevant for adjuvant therapy in HER-2/neu positive breast cancer and for cases where the cancer has metastasized.

Career Highlights

Throughout his career, Kotha J Subbaramaiah has worked with esteemed institutions, including Cornell University. His research and innovations have contributed to advancements in medical science, particularly in oncology and virology.

Collaborations

Some of his notable coworkers include Andrew J Dannenberg and David Stanley Pasco. Their collaborative efforts have furthered research in the medical field, enhancing the impact of their collective work.

Conclusion

Kotha J Subbaramaiah stands out as an influential inventor in the realm of medical treatments. His patents and research continue to pave the way for innovative solutions to pressing health issues.